Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement Axsome Therapeutics, Inc., a leading biopharmaceutical company revolutionising the treatment space of central nervous system (CNS) disorders, received acceptance from the U.S. Food and D...
Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company aiming to establish innovative therapies for the treatment of progressive kidney and gout diseases, unveiled...
Announcement Cogent Biosciences, Inc., a leading biotechnology company dedicated to establishing accurate therapies for genetically defined diseases, has now submitted its promising New Drug Applicat...
Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an u...
Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its...
Announcement Nona Biosciences, a leading biotechnology company thoroughly modernising the discovery pathway via innovative technology platforms have now extended its unified development and explorato...
Announcement Mabwell, a leading innovation enthusiast biopharmaceutical company with a fully unified industry chain, has declared that it has received clearance from the U.S. Food and Drug Administra...
Announcement The China-based Innovent Biologics, Inc., a leading biopharmaceutical company that focuses on establishing, manufacturing, and marketing quality-standard medicines for curing autoimmune,...
Announcement IRLAB Therapeutics AB, a leading company aimed on developing and exploring new treatments for Parkinson’s disease, announced that it has received a green signal for its Phase IB st...
Announcement Next Gen Diagnostics announced the exciting offshoot of its Infection Prevention division into an independent and strong-headed company from 1st January 2026. The company will be called ...
Speak with a healthcare analyst about your research, consulting, or platform needs.